Warning Letter Wednesday® Posts
A weekly exploration of FDA warning letters and enforcement trends
Takeaway -
Do's and don'ts of puffery
Takeaway -
Clinical study parameters must match claims
Takeaway -
Websites are considered “labeling”
Takeaway -
Implied marketing statements should be compliant
Takeaway -
Inflammation + arthritis claims = warning letter
Takeaway -
Old blogs & posts are “active” marketing
Takeaway -
Product tags are marketing claims
Takeaway -
Distributors are responsible for products they sell
Takeaway -
Review old videos for compliance
Takeaway -
Review old social posts for regulatory “landmines”
Takeaway -
Companies are responsible for co-manufactured products
Takeaway -
Influencers must disclose material connection